DISEASE INDICATIONS: Risk of cardiovascular events
MANUFACTURER: Novartis
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Entresto is a combination medication used to treat chronic heart failure in adults, containing sacubitril and valsartan.
